GlobeNewswire Inc.·Apr 23·Orion CorporationOrion Lifts 2026 Outlook After Strong Q1 Surge Driven by Nubeqa RoyaltiesFinnish pharma $ORION reported 17.8% Q1 revenue growth to €417.7M, raised full-year guidance citing Nubeqa royalties and pipeline progress. OECrevenue growthclinical trial
GlobeNewswire Inc.·Feb 24·NaGabelli Convenes Specialty Chemicals Leaders for Annual Strategy ForumGabelli Funds hosts its 17th Annual Specialty Chemicals Symposium on March 19, 2026, bringing together industry executives and investors for discussions on market trends and strategic challenges. MTXBASFYARQMAGNCC+5specialty chemicalssymposium